Eli Lilly and Company (LLY)

Total asset turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 34,124,100 32,072,500 29,515,500 27,691,400 28,541,400 29,239,500 29,070,700 29,322,800 28,318,400 27,758,500 26,726,300 25,485,600 24,539,800 23,213,800 22,949,800 23,087,100 22,319,500 21,843,100 21,673,400 21,621,700
Total assets US$ in thousands 64,006,300 57,915,500 54,814,000 53,163,000 49,489,800 47,461,500 47,063,600 46,919,300 48,806,000 48,187,000 47,809,000 46,838,300 46,633,100 43,946,000 41,967,000 41,102,800 39,286,100 37,893,100 38,666,400 38,006,800
Total asset turnover 0.53 0.55 0.54 0.52 0.58 0.62 0.62 0.62 0.58 0.58 0.56 0.54 0.53 0.53 0.55 0.56 0.57 0.58 0.56 0.57

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $34,124,100K ÷ $64,006,300K
= 0.53

Lilly(Eli) & Co's total asset turnover has shown a declining trend over the last eight quarters. The company's total asset turnover ratio decreased from 0.58 in Q4 2022 to 0.53 in Q4 2023. This indicates that the company generated $0.53 in sales for every $1 of total assets during Q4 2023.

The downward trend in total asset turnover could suggest inefficiencies in asset utilization or decreasing sales relative to the size of the asset base. It may indicate that the company is not effectively generating revenue from its assets or that there are operational challenges impacting sales efficiency.

Further analysis of the factors affecting sales and asset management within the company may be necessary to address the declining trend in total asset turnover and improve overall financial performance.


Peer comparison

Dec 31, 2023


See also:

Eli Lilly and Company Total Asset Turnover (Quarterly Data)